Ultime notizie per Verona Pharma (NASDAQ:VRNA) Azioni

VERONA PHARMA PLC - ADR

Verona Pharma

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

News

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

CPRX

VRNA

Scopriamo i 3 titoli sanitari che potrebbero affrontare un crollo a causa di indicatori di mercato e RSI elevati.

Scopri i 3 titoli sanitari che potrebbero crollare ad agosto

Verona Pharma plc - American Depositary Shares

Verona Pharma PLC

Goldman Sachs analyst Neil Mehta maintains Atlas Energy Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AESI#NYSE">AESI</a>) with a Neutral and lowers the price target from $22 to $15.

Price Target

Analyst Ratings

AESI

Goldman Sachs Maintains Neutral on Atlas Energy Solutions, Lowers Price Target to $15

Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) CEO Andy Jassy gave some insight into the company's artificial intelligence strategy in his annual letter to shareholders<a href="https://www.benzinga.com/media/25/04/44729831/amazon-halts-orders-worth-over-500000-from-china-vietnam-and-other-asian-countries-following-trumps-tariff-plans-report"> released Thursday.&nbsp;</a>
The Details: Jassy outlined <a href="https://www.aboutamazon.com/news/company-news/amazon-ceo-andy-jassy-2024-letter-to-shareholders">the company's</a> strategic focus on generative AI as a transformative force and emphasized its potential to &#8220;reinvent virtually every customer experience.&#8221;&nbsp;
He highlighted the need for substantial capital to secure AI chips and build data centers, calling these investments &#8220;proactive&#8221; and beneficial for customers, shareholders and long-term growth.&nbsp;
Read Next:<a href="https://www.benzinga.com/25/04/44740737/inflation-cools-but-too-soon-to-blow-the-all-clear-economist-says"> Inflation Cools, But &#8216;Too Soon To Blow The All Clear,&#8217; Economist Says&nbsp;</a>
"We continue to believe AI is a once-in-a-lifetime reinvention of everything we know, the demand is unlike anything we've seen before, and our customers, shareholders, and business will be well-served by our investing aggressively now," Jassy wrote to shareholders.&nbsp;
The Amazon CEO stressed a "strong urgency to make inference less expensive for customers' pointed to the company's new Trainium2 chips as 30% to 40% less expensive than currently available GPU options. He predicted that more affordable AI training will ultimately lead to more overall AI spending and translate into a profitable business segment much like AWS.&nbsp;
"It's like what happened with AWS. Revolutionizing the cost of compute and storage happily led to lower cost per unit, and more invention, better customer experiences, and more absolute infrastructure spend," he wrote.&nbsp;
Jassy reiterated the need for large capital investments during the current period of "high demand" in order to remain competitive in the rapidly changing AI landscape.&nbsp;
"It won't all happen in a year or two, but it won't take 10 either. It's moving faster than almost anything technology has ever seen," Jassy said. 
AMZN Stock Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Amazon shares are down 5.30% at $180.98 amid a broad market sell-off at the time of publication Thursday.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/25/04/44695907/elon-musk-calls-trump-trade-advisor-peter-navarro-dumber-than-sack-of-bricks-defends-tesla-as-the-most-american-made-cars">Elon Musk Calls Trump Trade Advisor Peter Navarro &#8216;Dumber Than Sack Of Bricks,&#8217; Defends Tesla As &#8216;Most American-Made Cars&#8217;&nbsp;</a></li>
</ul>
Photo: Shutterstock

Large Cap

Management

Movers

Tech

AMZN

Amazon CEO Justifies Large AI Investments As 'Once-In-A-Lifetime Reinvention Of Everything We Know'

Goldman Sachs analyst Jordan Alliger maintains ArcBest (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCB#NASDAQ">ARCB</a>) with a Neutral and lowers the price target from $108 to $97.

ARCB

Goldman Sachs Maintains Neutral on ArcBest, Lowers Price Target to $97

<a href="https://www.youtube.com/watch?v=sk1lGGRgQmk" title="https://www.youtube.com/watch?v=sk1lGGRgQmk">https://www.youtube.com/watch?v=sk1lGGRgQmk</a>

President Trump Says Don't Know Why U.S. Steel Even Needs A Deal Now; U.S. Steel Is Going To Do Well Because Of Tariffs

Keros Therapeutics, Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KROS#NASDAQ">KROS</a>) board of directors initiated a formal review process on Thursday to evaluate strategic alternatives, <a href="https://www.benzinga.com/general/health-care">including a sale</a>.
&#8220;Consistent with our commitment to taking action to enhance stockholder value, Keros&#8217; board determined to undertake a review of all strategic alternatives available to the Company,&#8221; said Jean-Jacques Bienaimé, Lead Independent Director. &#8220;During the pendency of the strategic review process, we remain focused on the execution of our strategy.&#8221;
Keros intends to provide a preliminary update regarding the status of the process <a href="https://www.benzinga.com/pressreleases/25/04/g44729883/keros-therapeutics-announces-review-of-strategic-alternatives" target="_blank" rel="noreferrer noopener">within 60 days</a>.
The company also adopted a limited-duration stockholder rights plan, effective immediately. Investors have been rapidly accumulating common stock, including an individual investor with an 11.2% stake in the company.
In March, Keros Therapeutics announced initial topline results from the Phase 1 clinical trial of KER-065 in healthy volunteers through the multiple ascending dose <a href="https://www.benzinga.com/pressreleases/25/03/g44556909/keros-therapeutics-announces-initial-topline-results-from-the-phase-1-clinical-trial-of-ker-065-in" target="_blank" rel="noreferrer noopener">treatment period (Day 85)</a>.
The company said clinical data from this trial and preclinical data support KER-065&#8217;s therapeutic potential for Duchenne muscular dystrophy and other neuromuscular indications.
In its fourth-quarter earnings release, the company reported that cash and cash equivalents as of Dec. 31, 2024, were $559.9 million, and a $200 million upfront payment from the Takeda Agreement is expected to provide a cash runway into 2029.
Price Action: KROS stock is up 16.3% at $12.01 at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/media/25/04/44721053/disney-cuts-prices-and-adds-perks-to-lure-families-back-to-orlando-parks" target="_blank" rel="noreferrer noopener">Disney Cuts Prices And Adds Perks To Lure Families Back To Orlando Parks</a></li>
</ul>
Image: Shutterstock

Biotech

Health Care

General

KROS

Keros Therapeutics Goes Up For Sale On Heels Of Stockholder Rights Plan

Goldman Sachs analyst Mark Delaney maintains Amphenol (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APH#NYSE">APH</a>) with a Buy and lowers the price target from $89 to $72.

Goldman Sachs Maintains Buy on Amphenol, Lowers Price Target to $72

<a href="https://www.youtube.com/watch?v=sk1lGGRgQmk">https://www.youtube.com/watch?v=sk1lGGRgQmk</a>

Macro Economic Events

Politics

Global

Economics

President Trump Says Looking At EU As One Block On Tariffs

WIIM

ABCB

BANR

BPOP

CATY

CUBI

CVBF

FCNCA

FFBC

FFIN

FIBK

FRME

GBCI

HIFS

IBOC

INBK

INDB

MBCN

PNFP

RNST

SBCF

SFBS

SFNC

TBBK

TCBI

TFIN

UBSI

UMBF

WAFD

WSBC

WSFS

WTFC

Shares of banking companies are trading lower as stocks pull back after surging Wednesday following President Trump's tariff pause announcement.

<a href="https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-plans-invest-23-billion-us-plants-trump-renews-drug-tariff-threats-2025-04-10/#:~:text=April%2010%20(Reuters)%20%2D%20Swiss,duties%20from%20the%20Trump%20administration.">https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-plans-invest-23-billion-us-plants-trump-renews-drug-tariff-threats-2025-04-10/#:~:text=April%2010%20(Reuters)%20%2D%20Swiss,duties%20from%20the%20Trump%20administration.</a>
&nbsp;

'Novartis Plans To Spend $23B To Build And Expand 10 U.S. Facilities; The New Sites And Extensions Will Be Built Over Five Years And Are Expected To Create More Than 4,000 Jobs; New Facilities Include 6 Manufacturing Plants And A Research And Development Site' - Reuters News

President Trump Says Would Love To Get Deal With China; Think We Will End Up Working Out Something Good For Both Countries; U.S. Treasury Secretary Bessent Says As We Settle With Countries, We Will End Up In Place Of Certainty

Costco Wholesale Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>) reported upbeat March sales on Wednesday. Here are <a href="https://www.benzinga.com/topic/retail-stocks">some key analyst takeaways</a>.
<ul>
<li>Goldman Sachs <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58580bcbee7bf60001bcfa29/kate-mcshane">analyst Kate McShane</a> maintained a Buy rating, while raising the price target from $1,102 to $1,118.</li>
<li>JPMorgan <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/584847d9ee7bf6000154d225/christopher-horvers">analyst Christopher Horvers</a> reiterated an Overweight rating and price target of $1,070.</li>
<li>Telsey Advisory Group <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5e301e08430dee0001c88c8d/joseph-feldman">analyst Joseph Feldman</a> reaffirmed an Outperform rating and price target of $1,100.</li>
</ul>
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Goldman Sachs: Costco reported March same-store sales, excluding gas and forex impact, of 9.1%. It significantly beat consensus of 7.4% and accelerated from February's 8.3%.
U.S. comparable sales came in at 8.7%, above consensus of 7.7% and accelerating from 8.6% in February, McShane noted.
"Worldwide traffic accelerated to +6.1% in March (vs. +5.0% in February, +7.1% in January, and +5.5% in December), while overall global ticket (ex-gas/FX) increased an estimated +2.9% (vs. +3.2% in February, +2.7% in January, and +4.3% in December)," the analyst wrote. She raised the earnings estimate for the fiscal third quarter from $4.25 per share to $4.29 per share.
JPMorgan: While U.S. traffic grew 6.1%, Canada and Other International core comps were strong at 10.6% and +9.9%, respectively, "indicating no pullback in international segments as a result of US boycotts," Horvers said. "E-commerce sales were +17.5% ex-FX," he added.
There was an uptick in momentum, particularly in electronics, and "likely related to tariff pricing fears," the analyst stated. For April, the US core comp could come in at 6.5%, Canada at 8%, and Other International at 7%, "resulting in total company core comp of +6.8%," he further wrote.
Telsey Advisory Group: Costco reported "impressive" March same-store sales, Feldman said. "Costco continues to execute well in this uncertain operating environment," he added.
The company is poised to continue generating strong earnings growth, "driven by a MSD comp, membership fee income growth of HSD, effective management of merchandising and costs, and leverage of customer data," the analyst wrote. He projected April headline comp of 4.5%, versus 5.6% last year.
Price Action: Costco shares declined by 0.91% to $956.4 at the time of publication on Thursday.
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/03/44491397/dollar-tree-q4-earnings-surpass-estimates-unloads-family-dollar-for-1b">Ford, GM To Witness &#8216;Higher Demand&#8217; As American Carmakers Set To &#8216;Reap The Fruit Of Protectionism,&#8217; Says Expert: Here&#8217;s A List Of Potential Gainers And Losers From Trump Tariffs</a></li>
</ul>
Image: Shutterstock

Analyst Color

Reiteration

COST

Costco Posts Strong March Sales, Analysts Highlight Uptick In Purchases Ahead Of Tariffs

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$40.00</td>
<td>$46.8K</td>
<td>7.3K</td>
<td>9.7K</td>
</tr>
<tr>
<td>PYPL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$70.00</td>
<td>$72.4K</td>
<td>15.2K</td>
<td>5.1K</td>
</tr>
<tr>
<td>BAC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$36.00</td>
<td>$39.6K</td>
<td>2.7K</td>
<td>3.2K</td>
</tr>
<tr>
<td>ALLY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$35.00</td>
<td>$260.5K</td>
<td>8.7K</td>
<td>2.0K</td>
</tr>
<tr>
<td>WFC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$67.50</td>
<td>$89.7K</td>
<td>4.5K</td>
<td>744</td>
</tr>
<tr>
<td>SYF</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$45.00</td>
<td>$59.2K</td>
<td>146</td>
<td>592</td>
</tr>
<tr>
<td>COIN</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>04/17/25</td>
<td>$165.00</td>
<td>$31.6K</td>
<td>631</td>
<td>486</td>
</tr>
<tr>
<td>C</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$32.50</td>
<td>$28.9K</td>
<td>219</td>
<td>350</td>
</tr>
<tr>
<td>V</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$360.00</td>
<td>$43.5K</td>
<td>7.9K</td>
<td>278</td>
</tr>
<tr>
<td>BN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$55.00</td>
<td>$50.3K</td>
<td>825</td>
<td>272</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• Regarding HOOD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>), we observe a call option trade with bullish sentiment. It expires in 7 day(s) on April 17, 2025. Parties traded 200 contract(s) at a $40.00 strike. The total cost received by the writing party (or parties) was $46.8K, with a price of $234.0 per contract. There were 7341 open contracts at this strike prior to today, and today 9779 contract(s) were bought and sold. 
• For PYPL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>), we notice a call option trade that happens to be bearish, expiring in 71 day(s) on June 20, 2025. This event was a transfer of 400 contract(s) at a $70.00 strike. The total cost received by the writing party (or parties) was $72.4K, with a price of $181.0 per contract. There were 15288 open contracts at this strike prior to today, and today 5198 contract(s) were bought and sold. 
• For BAC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>), we notice a call option sweep that happens to be bullish, expiring in 7 day(s) on April 17, 2025. This event was a transfer of 300 contract(s) at a $36.00 strike. This particular call needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $39.6K, with a price of $132.0 per contract. There were 2719 open contracts at this strike prior to today, and today 3215 contract(s) were bought and sold. 
• For ALLY (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLY#NYSE">ALLY</a>), we notice a put option sweep that happens to be bearish, expiring in 71 day(s) on June 20, 2025. This event was a transfer of 501 contract(s) at a $35.00 strike. This particular put needed to be split into 36 different trades to become filled. The total cost received by the writing party (or parties) was $260.5K, with a price of $520.0 per contract. There were 8758 open contracts at this strike prior to today, and today 2000 contract(s) were bought and sold. 
• For WFC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>), we notice a call option sweep that happens to be bullish, expiring in 71 day(s) on June 20, 2025. This event was a transfer of 299 contract(s) at a $67.50 strike. This particular call needed to be split into 6 different trades to become filled. The total cost received by the writing party (or parties) was $89.7K, with a price of $300.0 per contract. There were 4595 open contracts at this strike prior to today, and today 744 contract(s) were bought and sold. 
• For SYF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYF#NYSE">SYF</a>), we notice a put option sweep that happens to be bullish, expiring in 7 day(s) on April 17, 2025. This event was a transfer of 311 contract(s) at a $45.00 strike. This particular put needed to be split into 14 different trades to become filled. The total cost received by the writing party (or parties) was $59.2K, with a price of $195.0 per contract. There were 146 open contracts at this strike prior to today, and today 592 contract(s) were bought and sold. 
• For COIN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), we notice a call option trade that happens to be neutral, expiring in 7 day(s) on April 17, 2025. This event was a transfer of 35 contract(s) at a $165.00 strike. The total cost received by the writing party (or parties) was $31.6K, with a price of $905.0 per contract. There were 631 open contracts at this strike prior to today, and today 486 contract(s) were bought and sold. 
• Regarding C (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>), we observe a put option trade with bearish sentiment. It expires in 162 day(s) on September 19, 2025. Parties traded 349 contract(s) at a $32.50 strike. The total cost received by the writing party (or parties) was $28.9K, with a price of $83.0 per contract. There were 219 open contracts at this strike prior to today, and today 350 contract(s) were bought and sold. 
• For V (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>), we notice a call option sweep that happens to be bearish, expiring in 71 day(s) on June 20, 2025. This event was a transfer of 100 contract(s) at a $360.00 strike. This particular call needed to be split into 17 different trades to become filled. The total cost received by the writing party (or parties) was $43.5K, with a price of $435.0 per contract. There were 7996 open contracts at this strike prior to today, and today 278 contract(s) were bought and sold. 
• For BN (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BN#NYSE">BN</a>), we notice a call option sweep that happens to be bearish, expiring in 99 day(s) on July 18, 2025. This event was a transfer of 272 contract(s) at a $55.00 strike. This particular call needed to be split into 13 different trades to become filled. The total cost received by the writing party (or parties) was $50.3K, with a price of $185.0 per contract. There were 825 open contracts at this strike prior to today, and today 272 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

ALLY

COIN

HOOD

PYPL

10 Financials Stocks With Whale Alerts In Today's Session

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/11/25</td>
<td>$250.00</td>
<td>$26.0K</td>
<td>12.1K</td>
<td>41.6K</td>
</tr>
<tr>
<td>LTH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/17/25</td>
<td>$40.00</td>
<td>$54.0K</td>
<td>3.0K</td>
<td>2.6K</td>
</tr>
<tr>
<td>BABA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$110.00</td>
<td>$726.6K</td>
<td>4.4K</td>
<td>2.3K</td>
</tr>
<tr>
<td>PDD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$75.00</td>
<td>$53.1K</td>
<td>2.2K</td>
<td>1.0K</td>
</tr>
<tr>
<td>NKE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$50.00</td>
<td>$44.4K</td>
<td>4.3K</td>
<td>935</td>
</tr>
<tr>
<td>JD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$30.00</td>
<td>$43.5K</td>
<td>3.4K</td>
<td>669</td>
</tr>
<tr>
<td>GME</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/09/25</td>
<td>$25.00</td>
<td>$39.8K</td>
<td>495</td>
<td>632</td>
</tr>
<tr>
<td>CBRL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$32.50</td>
<td>$81.5K</td>
<td>1.1K</td>
<td>538</td>
</tr>
<tr>
<td>CPRI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/11/25</td>
<td>$13.00</td>
<td>$71.6K</td>
<td>534</td>
<td>422</td>
</tr>
<tr>
<td>SBUX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$75.00</td>
<td>$181.7K</td>
<td>5.5K</td>
<td>275</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• Regarding TSLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), we observe a call option trade with bearish sentiment. It expires in 1 day(s) on April 11, 2025. Parties traded 50 contract(s) at a $250.00 strike. The total cost received by the writing party (or parties) was $26.0K, with a price of $520.0 per contract. There were 12165 open contracts at this strike prior to today, and today 41693 contract(s) were bought and sold. 
• Regarding LTH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LTH#NYSE">LTH</a>), we observe a call option sweep with bullish sentiment. It expires in 190 day(s) on October 17, 2025. Parties traded 400 contract(s) at a $40.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $54.0K, with a price of $135.0 per contract. There were 3099 open contracts at this strike prior to today, and today 2677 contract(s) were bought and sold. 
• For BABA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), we notice a call option trade that happens to be bullish, expiring in 162 day(s) on September 19, 2025. This event was a transfer of 600 contract(s) at a $110.00 strike. The total cost received by the writing party (or parties) was $726.6K, with a price of $1211.0 per contract. There were 4435 open contracts at this strike prior to today, and today 2383 contract(s) were bought and sold. 
• Regarding PDD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>), we observe a put option sweep with bullish sentiment. It expires in 7 day(s) on April 17, 2025. Parties traded 591 contract(s) at a $75.00 strike. This particular put needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $53.1K, with a price of $90.0 per contract. There were 2281 open contracts at this strike prior to today, and today 1004 contract(s) were bought and sold. 
• For NKE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>), we notice a put option sweep that happens to be bearish, expiring in 71 day(s) on June 20, 2025. This event was a transfer of 111 contract(s) at a $50.00 strike. This particular put needed to be split into 25 different trades to become filled. The total cost received by the writing party (or parties) was $44.4K, with a price of $400.0 per contract. There were 4309 open contracts at this strike prior to today, and today 935 contract(s) were bought and sold. 
• Regarding JD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>), we observe a put option trade with bearish sentiment. It expires in 36 day(s) on May 16, 2025. Parties traded 500 contract(s) at a $30.00 strike. The total cost received by the writing party (or parties) was $43.5K, with a price of $87.0 per contract. There were 3448 open contracts at this strike prior to today, and today 669 contract(s) were bought and sold. 
• Regarding GME (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>), we observe a put option trade with bullish sentiment. It expires in 29 day(s) on May 9, 2025. Parties traded 166 contract(s) at a $25.00 strike. The total cost received by the writing party (or parties) was $39.8K, with a price of $240.0 per contract. There were 495 open contracts at this strike prior to today, and today 632 contract(s) were bought and sold. 
• For CBRL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBRL#NASDAQ">CBRL</a>), we notice a put option sweep that happens to be bearish, expiring in 71 day(s) on June 20, 2025. This event was a transfer of 326 contract(s) at a $32.50 strike. This particular put needed to be split into 29 different trades to become filled. The total cost received by the writing party (or parties) was $81.5K, with a price of $250.0 per contract. There were 1133 open contracts at this strike prior to today, and today 538 contract(s) were bought and sold. 
• Regarding CPRI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPRI#NYSE">CPRI</a>), we observe a call option trade with bearish sentiment. It expires in 1 day(s) on April 11, 2025. Parties traded 400 contract(s) at a $13.00 strike. The total cost received by the writing party (or parties) was $71.6K, with a price of $179.0 per contract. There were 534 open contracts at this strike prior to today, and today 422 contract(s) were bought and sold. 
• Regarding SBUX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>), we observe a put option trade with bearish sentiment. It expires in 281 day(s) on January 16, 2026. Parties traded 250 contract(s) at a $75.00 strike. The total cost received by the writing party (or parties) was $181.7K, with a price of $727.0 per contract. There were 5568 open contracts at this strike prior to today, and today 275 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BABA

CBRL

CPRI

Citigourp Global Markets 2% Protected Notes Linked To The Djia

SBUX

TSLA

10 Consumer Discretionary Stocks With Whale Alerts In Today's Session

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Below are some instances of options activity happening in the Information Technology sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/11/25</td>
<td>$108.00</td>
<td>$29.8K</td>
<td>33.1K</td>
<td>62.5K</td>
</tr>
<tr>
<td>PLTR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/11/25</td>
<td>$80.00</td>
<td>$27.0K</td>
<td>9.7K</td>
<td>12.0K</td>
</tr>
<tr>
<td>INTC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$22.00</td>
<td>$84.8K</td>
<td>31.8K</td>
<td>9.2K</td>
</tr>
<tr>
<td>MSTR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$305.00</td>
<td>$575.4K</td>
<td>1.4K</td>
<td>6.6K</td>
</tr>
<tr>
<td>WOLF</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$2.00</td>
<td>$30.0K</td>
<td>829</td>
<td>2.5K</td>
</tr>
<tr>
<td>AVGO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$200.00</td>
<td>$108.0K</td>
<td>10.1K</td>
<td>1.3K</td>
</tr>
<tr>
<td>DELL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$115.00</td>
<td>$52.5K</td>
<td>1.4K</td>
<td>874</td>
</tr>
<tr>
<td>TSM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$155.00</td>
<td>$26.5K</td>
<td>2.4K</td>
<td>792</td>
</tr>
<tr>
<td>LRCX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$60.00</td>
<td>$34.3K</td>
<td>1.0K</td>
<td>697</td>
</tr>
<tr>
<td>AMD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/20/26</td>
<td>$155.00</td>
<td>$108.6K</td>
<td>1.8K</td>
<td>664</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• Regarding NVDA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), we observe a call option trade with bullish sentiment. It expires in 1 day(s) on April 11, 2025. Parties traded 139 contract(s) at a $108.00 strike. The total cost received by the writing party (or parties) was $29.8K, with a price of $215.0 per contract. There were 33144 open contracts at this strike prior to today, and today 62502 contract(s) were bought and sold. 
• For PLTR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>), we notice a put option sweep that happens to be bullish, expiring in 1 day(s) on April 11, 2025. This event was a transfer of 410 contract(s) at a $80.00 strike. This particular put needed to be split into 24 different trades to become filled. The total cost received by the writing party (or parties) was $27.0K, with a price of $66.0 per contract. There were 9719 open contracts at this strike prior to today, and today 12047 contract(s) were bought and sold. 
• Regarding INTC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>), we observe a call option sweep with bullish sentiment. It expires in 36 day(s) on May 16, 2025. Parties traded 786 contract(s) at a $22.00 strike. This particular call needed to be split into 31 different trades to become filled. The total cost received by the writing party (or parties) was $84.8K, with a price of $108.0 per contract. There were 31860 open contracts at this strike prior to today, and today 9251 contract(s) were bought and sold. 
• For MSTR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), we notice a call option sweep that happens to be bearish, expiring in 7 day(s) on April 17, 2025. This event was a transfer of 1019 contract(s) at a $305.00 strike. This particular call needed to be split into 13 different trades to become filled. The total cost received by the writing party (or parties) was $575.4K, with a price of $563.0 per contract. There were 1484 open contracts at this strike prior to today, and today 6664 contract(s) were bought and sold. 
• Regarding WOLF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>), we observe a call option sweep with bearish sentiment. It expires in 36 day(s) on May 16, 2025. Parties traded 500 contract(s) at a $2.00 strike. This particular call needed to be split into 23 different trades to become filled. The total cost received by the writing party (or parties) was $30.0K, with a price of $60.0 per contract. There were 829 open contracts at this strike prior to today, and today 2527 contract(s) were bought and sold. 
• Regarding AVGO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>), we observe a call option trade with bearish sentiment. It expires in 71 day(s) on June 20, 2025. Parties traded 135 contract(s) at a $200.00 strike. The total cost received by the writing party (or parties) was $108.0K, with a price of $800.0 per contract. There were 10154 open contracts at this strike prior to today, and today 1301 contract(s) were bought and sold. 
• Regarding DELL (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>), we observe a call option trade with bullish sentiment. It expires in 281 day(s) on January 16, 2026. Parties traded 125 contract(s) at a $115.00 strike. The total cost received by the writing party (or parties) was $52.5K, with a price of $420.0 per contract. There were 1469 open contracts at this strike prior to today, and today 874 contract(s) were bought and sold. 
• For TSM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>), we notice a call option trade that happens to be bearish, expiring in 7 day(s) on April 17, 2025. This event was a transfer of 50 contract(s) at a $155.00 strike. The total cost received by the writing party (or parties) was $26.5K, with a price of $530.0 per contract. There were 2448 open contracts at this strike prior to today, and today 792 contract(s) were bought and sold. 
• Regarding LRCX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>), we observe a put option sweep with bullish sentiment. It expires in 162 day(s) on September 19, 2025. Parties traded 50 contract(s) at a $60.00 strike. This particular put needed to be split into 10 different trades to become filled. The total cost received by the writing party (or parties) was $34.3K, with a price of $690.0 per contract. There were 1039 open contracts at this strike prior to today, and today 697 contract(s) were bought and sold. 
• Regarding AMD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), we observe a call option trade with bullish sentiment. It expires in 344 day(s) on March 20, 2026. Parties traded 300 contract(s) at a $155.00 strike. The total cost received by the writing party (or parties) was $108.6K, with a price of $362.0 per contract. There were 1846 open contracts at this strike prior to today, and today 664 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AVGO

DELL

INTC

LRCX

MSTR

NVDA

PLTR

WOLF

10 Information Technology Stocks With Whale Alerts In Today's Session

<ul>
<li>The recent tariff-induced cryptocurrency market rout has sparked COVID-19 crash comparisons.</li>
<li>The March 2020 COVID-19 market crash was one of the worst on record for the cryptocurrency market.</li>
<li>Bitcoin and the broader cryptocurrency market may still have further to fall.</li>
</ul>
The past few weeks have been turbulent for cryptocurrency markets. <a href="https://www.benzinga.com/government/regulations/25/04/44618089/trumps-tariffs-surprise-triggers-carnage-magnificent-7-set-to-wipe-out-nearly-700-billion-in-market-value">President Donald Trump&#8216;s &#8220;reciprocal tariffs&#8221;</a> last week only intensified the situation.
Bitcoin, the largest cryptocurrency by market capitalization, has tanked as much as 16% since the announcement to trade at five-month lows below $75,000. Ethereum, the second largest cryptocurrency, has had it worse, falling as much as 28% to nearly $1,400, levels not seen since March 2023.
Amid the market rout, many are comparing the current situation to the infamous COVID-19 crash, but how do they compare?
Don't Miss:
<ul>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> this is your last chance to become an investor for $0.80 per share.</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
</ul>
<h2 class="wp-block-heading">Another COVID Crash?</h2>
As Bitcoin tanked roughly 8% from over $81,000 to about $74,500 early on Monday amid tariff panic, many thoughts were turned to the March 2020 COVID-19 crash.&nbsp;
&#8220;Black Swan in crypto today. This scenario is similar to the Covid dump with almost a 1:1 match,&#8221; well-followed market analyst Jonathan Carter <a href="https://x.com/JohncyCrypto/status/1909197119933587663?t=HZ1mFTCeLuUDla0kouyY9w&amp;s=19">asserted</a> on X.
On the other hand, fellow prominent analyst &#8220;Tyler Durden&#8221; <a href="https://x.com/TylerDurden/status/1909106297485795536?t=VovUPaFi4t4xT1O5fQjzvQ&amp;s=19">wrote</a>, &#8220;Still not even 10% of the feeling of March covid crash.&#8221;
These sentiments necessitate a fresh look at what happened during the COVID-19 cryptocurrency crash.
Trending: Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.55 per share now</a>.
<h2 class="wp-block-heading">World&#8217;s Apart?</h2>
The COVID-19 pandemic shook the world to its core, disrupting nearly every aspect of society. These disruptions were reflected in global financial markets, including the cryptocurrency market.
When then-President Trump declared the pandemic a national emergency on March 13, 2020, the total cryptocurrency market capitalization tanked by nearly 40% from almost $224 billion to $135 billion, its worst intraday crash on record.
Bitcoin also saw its worst intraday correction on record, plummeting over 35% from around $7,000 to below $4,500. As is typically the case, Ethereum saw an even worse correction, falling 43% on the day, but it was only its second-worst correction on record.
Bitcoin continued this drop to trade as low as $3,800, marking a nearly 64% decline from its yearly high above $10,000. Ethereum, on the other hand, fell as much as 69%.
By comparison, Trump&#8217;s &#8220;Liberation Day&#8221; tariffs only sparked a 3.5% cryptocurrency market capitalization from nearly $2.8 trillion to $2.6 trillion on the day.
See Also: <a href="https://www.benzinga.com/money/vatom-adv">Invest in the Future of Digital Engagement. Own a Piece of the $100 Billion Metaverse Today for Just $500.</a>
Bitcoin also only recorded an initial 3% price decline from $88,500 to nearly $82,000. Furthermore, in the extended fallout, the asset has only dropped about 32% from its yearly high of $109,600 to $74,500.
Ethereum, meanwhile, dropped 6% on the initial announcement, though it has dropped as much as 62% from its yearly high.
The data suggests that the cryptocurrency market&#8217;s reaction to Trump tariffs has been nowhere near the COVID-19 crash. This could indicate greater market maturity or suggest that there is more room to fall.
The situation is not helped by the fact that Trump does not appear to be considering a pause on the controversial fresh tariffs as some had hoped. Instead, <a href="https://www.benzinga.com/government/regulations/25/04/44670193/wall-street-turmoil-deepens-as-trump-threatens-massive-china-tariffs-bitcoin-wobbles-at-78k-whats-driving-markets-monday">he has doubled down</a> with threats of more tariffs on China.
At the same time, the Federal Reserve has poured cold water on hopes of a near intervention. Speaking with journalists on Friday, <a href="https://www.benzinga.com/25/04/44661029/trump-and-fed-stand-firm-lack-of-a-put-could-drive-the-market-lower-very-quickly-warns-expert">Fed Chair Jerome Powell suggested</a> the central bank was adopting a wait-and-see approach.
Read Next:
<ul>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>

Personal Finance

Crypto Slump On Trump Tariff Sparks COVID Crash Comparisons: Here's How They Compare

Fartcoin (CRYPTO: FARTCOIN) has soared nearly 85% in the past week, mimicking the early stages of Pepe's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">PEPE</a>) <a href="https://www.benzinga.com/money/pepe-price-prediction">legendary meme coin run.</a>
What Happened: In an X post on Wednesday, prominent trader Unipcs shared his long position on Fartcoin, which is $3.2 million in profit.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">now up $3.2 million on my fartcoin long i wonder what this would look like when fartcoin is back at $1 &#x1f914;&#xFE0F;&#xFE0F;&#xFE0F;&#xFE0F;&#xFE0F;&#xFE0F; <a href="https://t.co/O1SvYWgQJZ">https://t.co/O1SvYWgQJZ</a> <a href="https://t.co/3tiP5z2pC3">pic.twitter.com/3tiP5z2pC3</a>
&mdash; Unipcs (aka &#39;Bonk Guy&#39;) &#x1f392; (@theunipcs) <a href="https://twitter.com/theunipcs/status/1910026724848312404?ref_src=twsrc%5Etfw">April 9, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
In another <a href="https://x.com/theunipcs/status/1910083928838525216">post</a>, the trader noted how similar Fartcoin looks to Pepe before its big bull run:
<ul>
<li>High spot volume despite zero major centralized listings on exchanges like Coinbase. </li>
<li>Massive futures volume, outpacing PEPE, TRUMP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">TRUMP</a>), Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>) and others.</li>
<li>Unmatched mindshare in the meme coin space currently, more than Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>).</li>
</ul>
Also Read: <a href="https://in.benzinga.com/markets/cryptocurrency/25/04/44696527/forget-dogecoin-shiba-inufartcoin-emerges-as-recession-hedge-with-surging-strength">Forget Dogecoin, Shiba Inu—Fartcoin Emerges As &#8216;Recession Hedge&#8217; With Surging Strength</a>
What's Next: Other traders agree with Unipcs, pointing to Fartcoin&#8217;s strength on higher timeframes.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Fartcoin what if&#8230; <a href="https://t.co/ufHHr1VDeP">pic.twitter.com/ufHHr1VDeP</a>
&mdash; Altcoin Sherpa (@AltcoinSherpa) <a href="https://twitter.com/AltcoinSherpa/status/1910332845697999034?ref_src=twsrc%5Etfw">April 10, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Trader Crypto General <a href="https://x.com/DaCryptoGeneral/status/1909654370410807642?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1909654370410807642%7Ctwgr%5Ea547f22260be8178a546da4d72d97ad9c1301b0c%7Ctwcon%5Es1_&amp;ref_url=https%3A%2F%2Fcryptonews.com%2Fexclusives%2Ffartcoin-price-is-pumping-over-200-in-30-days-now-what%2F">sees</a> strength and notes the meme coin appears to have bottomed out and is consolidating above a key breakout level.
Read Next:
<ul>
<li><a href="https://in.benzinga.com/trading-ideas/movers/25/04/44660568/fartcoin-returns-over-8-in-a-week-marked-by-dogecoin-ethereum-bloodbath">Fartcoin Returns Over 8% In A Week Marked By Dogecoin, Ethereum Bloodbath</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$DOGE

$PEPE

$SHIB

$TRUMP

Millionaire Trader Rakes In $1 Million On The Meme Coin That's Outpacing Dogecoin, Shiba Inu

ACVA

AEHL

ALIT

ALLE

ALSN

ARRY

BLNK

CHRW

CISS

CLVT

CRGO

CSLR

CTOS

EXPD

FBIN

FERG

FTAI

GNRC

HAYW

HUBG

IPDN

JOBY

MATX

MGRC

MLKN

NVRI

PAYC

PAYX

PCTY

PSIX

REZI

SCWO

SHLS

TREX

VCIG

VICR

VLTO

VSEC

VSTS

Shares of companies within the broader industrial sector are trading lower as stocks pull back after surging Wednesday following President Trump's tariff pause announcement.

The U.S. Food and Drug Administration approved DexCom, Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>) Dexcom G7 15-Day Continuous Glucose Monitoring System for people <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b44732771/dexcom-g7-15-day-receives-fda-clearance-the-longest-lasting-wearable-and-most-accurate-cgm-system" rel="noreferrer noopener">over 18 with diabetes</a>.
With an overall Mean Absolute Relative Difference (MARD) of 8.0%, Dexcom G7 15 Day builds on the performance of Dexcom CGM, which is clinically proven to lower A1C, reduce hyper- and hypoglycemia, and <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">increase time in range</a>.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/04/44652075/us-tariffs-spare-drugmakers-but-threaten-diabetes-device-industry" rel="noreferrer noopener">Trump Tariffs Spare Drugmakers But Threaten Diabetes Device Industry</a>
New with Dexcom G7 15 Day
<ul>
<li>Longest lasting CGM system with 15.5 days of wear.</li>
<li>Easier glucose management with fewer monthly sensors and reduced monthly waste.</li>
</ul>
Dexcom G7 features included with Dexcom G7 15 Day
<ul>
<li>The only waterproof CGM available.</li>
<li>Manage diabetes hands-free. The sensor connects directly to the patient&#8217;s Apple Watch.</li>
<li>Automated activity logging, simplified meal logging, and new medication logging to better understand how activity, food, and medications impact your glucose in real time.</li>
<li>12-hour grace period to replace finished sensors for a more seamless transition between sessions.</li>
<li>Simple mobile app with Dexcom Clarity integration to easily view glucose patterns, trends, and statistics via various interactive reports.</li>
<li>Ability to remotely share glucose numbers with caregivers and loved ones for added support and peace of mind.</li>
<li>Enhanced and customizable alert settings for improved discretion.</li>
</ul>
Dexcom is working closely with its insulin pump partners to ensure that Dexcom G7 15 Day will be compatible with automated insulin delivery systems upon launch.
Dexcom G7 15 Day is expected to launch in the U.S. in the second half of 2025.
Price Action: DXCM stock is up 0.22% at $66.99 at the last check on Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/25/04/44721086/annexons-investigational-drug-shows-rapid-recovery-and-durable-benefit-in-rare-neurological-disorder" target="_blank" rel="noreferrer noopener">Annexon&#8217;s Investigational Drug Shows Rapid Recovery And Durable Benefit In Rare Neurological Disorder</a></li>
</ul>

DXCM

FDA Approves Dexcom's 15-Day Wearable Glucose Management System. Company Plans US Launch

CGNX

COHR

EXTR

FLEX

KEYS

LITE

TRMB

VSAT

Shares of electronics and communication equipment stocks are trading lower amid overall tech weakness as stocks pull back after surging Wednesday following President Trump's tariff pause announcement.

Argentina's cannabis future is being shaped not in Congress but in the provinces through local legislation, public–private research and bold, sustainable ventures like Proyecto Vallecitos. From Jujuy to Mendoza, regional leaders are driving forward a more pragmatic and science-based cannabis model, bypassing stalled national reforms and building a diversified ecosystem rooted in medicine, research, tourism, and rural revitalization.
<h3 class="wp-block-heading">Mendoza: From World-Class Wine To Cannabis Innovation</h3>
Mendoza is widely known as the heart of Argentina's wine industry, producing nearly 70% of the country&#8217;s wine and enjoying international prestige for its high-altitude Malbecs. But today, the province is also positioning itself as a leader in cannabis regulation and innovation.
This week, Mendoza&#8217;s legislature passed a law to create the <a href="https://elplanteo.com/mendoza-registro-cannabis-medicinal/">Registro Provincial del Cannabis y Cáñamo Industrial</a>, a provincial registry aimed at overseeing the legal cultivation, production, transportation and sale of cannabis and hemp for medicinal and industrial purposes. As reported by <a href="https://elplanteo.com/mendoza-registro-cannabis-medicinal/">El Planteo</a>, the law establishes a licensing system for companies, NGOs, civil associations and qualified patients, supported by a framework of traceability and compliance.
The legislation updates Mendoza's existing cannabis regulation (Ley Provincial N.º 9298) and emphasizes education, research and the development of a regional cannabis economy—while explicitly excluding adult-use cannabis for now.
"The goal is access for patients with specific pathologies, like refractory seizures or chronic pain," explained Daniel Llaver, president of the province's Health Commission.
Also read: <a href="https://www.benzinga.com/markets/cannabis/25/04/44716802/cannabis-stays-legal-in-germany-following-new-coalition-deal">Cannabis Stays Legal In Germany Following New Coalition Deal</a>
The law also promotes training programs for law enforcement, public officials and producers to reduce stigma and misinformation. It articulates its enforcement through the Ministry of Government, working alongside the Ministry of Production and ISCAMEN (Mendoza's agricultural health authority).
<h3 class="wp-block-heading">Proyecto Vallecitos: High-Altitude Cannabis Tourism</h3>
In the Andes foothills of Mendoza, a bold new experiment is underway to transform the once-abandoned ski resort town of Vallecitos into a high-altitude hub for cannabis tourism, cultivation and regenerative development.
Led by entrepreneur Gonzalo Llamas Bianchetti, <a href="https://elplanteo.com/turismo-cannabis-proyecto-vallecitos/">Proyecto Vallecitos</a> seeks to integrate cannabis and hemp into the region's economic and cultural identity—much like wine has done over the past century. "I want visitors to connect with the environment and themselves, learning about cannabis from legal, scientific and cultural perspectives," Llamas told El Planteo.
The initiative includes cultivating non-psychoactive cannabis varieties, eco-friendly lodging in geodesic domes made with hemp materials as well as educational tours through cannabis farms and the surrounding mountains. The project already holds valid licenses from INASE and ARICCAME for cultivation and research and has passed the complex permitting process required for building in a protected, high-altitude border zone.
"Cannabis can generate value across many levels—science, health, industry and tourism," Llamas added. "It's about creating a regenerative identity for Mendoza's mountain regions."
With plans for renewable energy use, efficient irrigation and on-site seed development, Vallecitos embodies a model that mixes rural innovation, ecological design, and cannabis-driven diversification—reminiscent of how the wine industry redefined Mendoza decades ago.
<h3 class="wp-block-heading">National Research: Cannabis For Preventing Chemotherapy-Induced Pain</h3>
While Mendoza builds the regulatory and tourism frameworks, scientific research from Jujuy is contributing to Argentina's broader cannabis momentum.
In collaboration with the Universidad Austral, researchers from CONICET's Institute for Translational Medicine (IIMT) conducted a three-year preclinical study using cannabinoid formulations from the state-run company <a href="https://elplanteo.com/cannava-cannabis-empresa-jujuy/">Cannava</a>. Published in Psychopharmacology, the <a href="https://elplanteo.com/cannabis-dolor-cancer-estudio-conicet-cannava/">study</a> found that certain THC–CBD oral combinations could prevent chemotherapy-induced neuropathic pain in rats—without worsening other chemotherapy side effects.
The most promising result came from a 1:1 CBD–THC formulation, which not only reduced cold-induced hypersensitivity but also restored spontaneous activity in test subjects. Crucially, none of the cannabinoid formulations increased toxicity or liver stress, and their preventive use proved more effective than reactive dosing.
While more studies are needed to translate these findings into human therapies, the study marks a major step in Argentina's contribution to cannabinoid science, which is backed by local production, public institutions, and national health objectives.
<h3 class="wp-block-heading">A New Cannabis Map For Argentina</h3>
Together, these developments represent a bottom-up evolution of Argentina's cannabis ecosystem. With Mendoza leading in regulation and tourism, Jujuy advancing clinical research and entrepreneurs crafting local experiences rooted in sustainability, the country&#8217;s cannabis model is becoming as varied as its geography.
Rather than waiting for a cohesive national stance on adult-use or industrial-scale production, Argentina's provinces are laying down frameworks for a new green economy—step by step, sector by sector, region by region.
Now Read: 
<ul>
<li><a href="https://www.benzinga.com/news/legal/25/04/44743798/chile-moves-to-legalize-adult-use-cannabis-with-backing-from-presidential-candidate">Chile Moves To Legalize Adult-Use Cannabis With Backing From Presidential Candidate</a></li>
</ul>
Photo: Shutterstock

Cannabis

Latin America

From Malbec To Marijuana: Argentina's Provincial Push Fuels Cannabis Tourism, Science And Policy

Earnings

Press Releases

Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Verona Pharma to Present at Jefferies London Healthcare Conference

Ligand Reports Third Quarter 2024 Financial Results and Raises 2024 Guidance

Verona Pharma Announces December 2024 Investor Conference Participation

Verona Pharma Reports Strong Ohtuvayre™ Launch and Provides Preliminary Fourth Quarter and Full Year 2024 Financial Highlights

Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update

Verona Pharma Announces March 2025 Investor Conference Participation

Verona Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Comments

Verona Pharma

Notizie

Ultime notizie per Verona Pharma (NASDAQ:VRNA) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO